Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-13
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
News release - English.pdf
Results 2026-05-13
Interim MD&A - English.pdf
Results 2026-05-13
Interim financial statements/report – English.pdf
Results 2026-05-01
Annual report - English.pdf
Results 2026-03-20
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYSTTM (etripamil) Nasal Spray for the Treatment of PSVT
News release - English.pdf
Results 2026-03-20 Financials
Annual MD&A - English.pdf
Results 2026-03-20 Financials
Annual report on form 10-K - English.pdf
Results 2026-03-20 Financials
Audited annual financial statements – English.pdf
News 2026-02-11
Code of conduct.pdf
Results 2025-12-15
Milestone Pharmaceuticals Receives FDA Approval of CARDAMYST™ (etripamil) Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia
News release - English.pdf
News 2025-12-15
Other.pdf
News 2025-11-12
News release - English.pdf
News 2025-11-12
Other.pdf
Results 2025-11-12 Financials
Interim MD&A - English.pdf
Results 2025-11-12 Financials
Interim financial statements/report – English.pdf
News 2025-08-12
Other.pdf
News 2025-08-12
News release - English.pdf
Results 2025-08-12 Financials
Interim MD&A - English.pdf
Results 2025-08-12 Financials
Interim financial statements/report – English.pdf
News 2025-07-14
Other.pdf
News 2025-07-11
Other.pdf
News 2025-07-11
News release - English.pdf
News 2025-06-16
News release - English.pdf